Abstract

Conventional angioplasty of cerebral vasospasm combines proximal balloon angioplasty (up to the first segment of cerebral arteries) with chemical angioplasty for distal arteries. Distal balloon angioplasty (up to the second segment of cerebral arteries) has been used in our center instead of chemical angioplasty since January 2015. We aimed to assess the effect of this new approach in patients with aneurysmal SAH. The occurrence, date, territory, and cause of any cerebral infarction were retrospectively determined and correlated to angioplasty procedures. Delayed cerebral infarction, new angioplasty in the territory of a previous angioplasty, angioplasty complications, 1-month mortality, and 6- to 12-month modified Rankin Scale ≤ 2 were compared between 2 periods (before-versus-after January 2015, from 2012 to 2017) with adjustment for age, sex, World Federation of Neurosurgical Societies score, and the modified Fisher grade. Three-hundred-ninety-two patients were analyzed (160 before versus 232 after January 2015). Distal balloon angioplasty was associated with the following: higher rates of angioplasty (43% versus 27%, P < .001) and intravenous milrinone (31% versus 9%, P < .001); lower rates of postangioplasty delayed cerebral infarction (2.2% versus 7.5%, P = .01) and new angioplasty (8% versus 19%, P = .003) independent of the rate of patients treated by angioplasty and milrinone; and the same rates of stroke related to angioplasty (3.6% versus 3.1%, P = .78), delayed cerebral infarction (7.7% versus 12.5%, P = .12), mortality (10% versus 11%, P = .81), and favorable outcome (79% versus 73%, P = .21). Our study suggests that distal balloon angioplasty is safe and decreases the risk of delayed cerebral infarction and the recurrence of vasospasm compared with conventional angioplasty. It fails to show a clinical benefit possibly because of confounding changes in adjuvant therapies of vasospasm during the study period.

Highlights

  • BACKGROUND AND PURPOSEConventional angioplasty of cerebral vasospasm combines proximal balloon angioplasty with chemical angioplasty for distal arteries

  • Distal balloon angioplasty was associated with the following: higher rates of angioplasty (43% versus 27%, P Ͻ .001) and intravenous milrinone (31% versus 9%, P Ͻ .001); lower rates of postangioplasty delayed cerebral infarction (2.2% versus 7.5%, P Ï­ .01) and new angioplasty (8% versus 19%, P Ï­ .003) independent of the rate of patients treated by angioplasty and milrinone; and the same rates of stroke related to angioplasty (3.6% versus 3.1%, P Ï­ .78), delayed cerebral infarction (7.7% versus 12.5%, P Ï­ .12), mortality (10% versus 11%, P Ï­ .81), and favorable outcome (79% versus 73%, P Ï­ .21)

  • Our study suggests that distal balloon angioplasty is safe and decreases the risk of delayed cerebral infarction and the recurrence of vasospasm compared with conventional angioplasty

Read more

Summary

Objectives

We aimed to assess the effect of this new approach in patients with aneurysmal SAH. The aim of this study was to compare historically the safety and efficacy of this new approach with the conventional approach using proximal balloon angioplasty and chemical angioplasty.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call